Company intelligence / Profile preview

Juno Pharmaceuticals

Montreal, Quebec, Canada

Ownership: Private
Development stage: Other

Overview

Juno Pharmaceuticals is a global specialty pharmaceutical company focused on the in-licensing, registration, and commercialization of niche and differentiated pharmaceutical products, primarily sterile injectables and specialty medications. With a broad product portfolio that serves unmet medical needs and hospital requirements, the company specializes in generic injectables for hospitals, sclerosing agents for vascular needs, and allergen extracts for allergy diagnosis and treatment. Its business centers on commercialized/registered products and niche licensing rather than classical clinical-stage R&D.

Therapeutic areas: ImmunologyCardiovascularOther
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Exclusive Canadian distributor for HollisterStier allergy products

Beyond the preview

Go deeper on Juno Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Juno Pharmaceuticals.

Explore the full profile